Cultural

Alamar Biosciences Establishes Commercial Presence in APAC Region with First ARGO HT Install at Hong Kong Center for Neurodegenerative Diseases

FREMONT,Calif.,Dec. 6,2024-- Alamar Biosciences,a company powering precision proteomics to enable the earliest detection of disease,is proud to announce its commercial presence in the Asia Pacific (AP

12-06

sky100 Hong Kong Observation Deck Winter Presents: Sky-High Hong Kong Christmas Party in HK Style

Celebrate the Festive Season with Kpop Sensation ICHILLIN\' Enjoy Stunning Christmas Decors with Surprise Gift Exchange

12-05

The Millionth Export of Chery TIGGO 7 Marks Milestone in Global Expansion Strategy

WUHU,China,Dec. 4,2024-- On November 1st,2024,the TIGGO product line reached a major milestone as the millionth Chery TIGGO 7 began its journey to the global market from Wuhu Port in China. Since its

12-05

ROYAL COMMISSION FOR ALULA'S ARABIAN LEOPARD CONSERVATION PROGRAMME WELCOMES BIRTH OF RARE TRIPLETS

A first forKSA,the triplets – two male and one female and a litter of two cubs – male and female – born earlier this summer

12-05

Umbra Selected for NRO's Strategic Commercial Enhancements Stage III, Strengthening U.S. SAR Capabilities

WASHINGTON,Dec. 4,2024-- Umbra,a vertically integrated space technology company operating the world\'s highest-resolution commercial Synthetic Aperture Radar (SAR) satellites,has been awarded the Sta

12-05

Witsbb Launches Major New Product! Elderberry Yeast β-glucan Drink Boosts Health for Sensitive Children

SYDNEY,Dec. 2,2024-- Recently,Witsbb,a pioneer in "allergy-free" nutrition,has launched its latest product – the Elderberry Yeast β-glucan drink. As an immune-boosting nutritional product

12-04

AdvantageClub.ai raises $4 Million from Axilor Ventures to expand in the US and Asia and add New Product Lines

MANILA,Philippines,Dec. 2,2024-- AdvantageClub.ai,a leader in employee engagement solutions,has raised $4 million in its latest funding round,bringing its total funding to $11 million. The round was l

12-04

Hong Kong Airlines Resumes Vancouver Service Offering Twice-weekly direct flights from 18 January 2025

HONG KONG,Dec. 2,2024-- Hong Kong Airlines celebrated its 18th anniversary on 28 November and announced the resumption of direct flights to Vancouver,Canada commencing 18 January 2025. The twice-weekl

12-04

Sustainable Energy Brand EBL to Unveil New Brand Identity and Innovative Power Solutions at CES 2025

SHENZHEN,China,Dec. 2,2024-- EBL,a pioneering sustainable energy brand committed to environmental protection,efficiency,and stability,is proud to announce that it will unveil its new brand image at CE

12-04

Hesai to Attend CES 2025, Launch Versatile New Mini 3D Lidar for Industrial and Robotic Applications

PALO ALTO,Calif.,Dec. 2,2024--Hesai (Nasdaq: HSAI),the global leader in lidar technology for robotics and industrial applications,autonomous driving,and ADAS,announced today that it will be exhibiting

12-04

Home Previous 70 71 72 73 74 75 76 Next Tail

10 Items Per Page (Page 73 / 102) Total 1020 Items

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map